Edison Pharmaceuticals, a San Jose, California-based drug developer to treat diseases that impair energy metabolism, has raised $4.25 million in a Series B round. http://edisonpharma.com
Edison Pharmaceuticals, a San Jose, California-based drug developer to treat diseases that impair energy metabolism, has raised $4.25 million in a Series B round. http://edisonpharma.com
Copyright PEI Media
Not for publication, email or dissemination